The plaintiffs in a class action suit against Avinger (NSDQ: AVGR) have approved the $5 million settlement that the company offered in March.
Shareholders sued the company and several of its officers and directors claiming that they made false and misleading statements about Avinger’s original product, Pantheris, in its 2015 initial public offering. Avinger makes image-guided, catheter-based atherectomy systems for treatment of peripheral artery disease. The company has already paid its $1.75 million portion of the settlement.